STOCK TITAN

Inspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Inspire Medical Systems, Inc. (NYSE: INSP) will announce its financial results for the first quarter of 2024 on May 7. The management team will conduct a conference call to discuss the results and recent business developments. The webcast will be accessible through the Inspire website.
Positive
  • None.
Negative
  • None.

MINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2024 after the close of trading on Tuesday, May 7. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q1 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q1 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443


Inspire Medical Systems will release its financial results for the first quarter of 2024 on May 7.

The webcast of Inspire's Q1 2024 earnings call can be accessed via the Investor Relations page of the Inspire website or through the provided link on the PR.

The conference call to discuss the financial results will begin at 5:00 p.m. Eastern Time.

The replay of the earnings call will be available on the Company's Investor Relations website approximately two hours after the event and will be archived on the site for two weeks.
Inspire Medical Systems Inc

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Stock Data

Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link
Health Technology, Medical Specialties
US
Golden Valley

About INSP

inspire medical systems, inc. is a medical devices company based out of 9700 63rd avenue north suite 200, maple grove, minnesota, united states.